{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:46:33Z","timestamp":1782279993971,"version":"3.54.5"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"3-4","funder":[{"DOI":"10.13039\/100007188","name":"Uniformed Services University of the Health Sciences","doi-asserted-by":"publisher","award":["HU00011920042"],"award-info":[{"award-number":["HU00011920042"]}],"id":[{"id":"10.13039\/100007188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007188","name":"Uniformed Services University of the Health Sciences","doi-asserted-by":"publisher","award":["HU00011920042"],"award-info":[{"award-number":["HU00011920042"]}],"id":[{"id":"10.13039\/100007188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,27]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Meta-analytic findings and clinical practice guidance recommend pharmacological (e.g., pregabalin, duloxetine, and milnacipran) and non-pharmacological (e.g., exercise and sleep hygiene) interventions to reduce symptoms and improve quality of life in people living with fibromyalgia. However, some of these therapies may lack robust evidence as to their efficacy, have side effects that may outweigh benefits, or carry risks. Although the annual prevalence of fibromyalgia in active duty service members was estimated to be 0.015% in 2018, the likelihood of receiving a fibromyalgia diagnosis was 9 times greater in patients assigned female than male and twice as common in non-Hispanic Black than White service members. Therefore, the primary goal of this retrospective study is to examine co-occurring conditions and pain-management care receipt in the 3 months before and 3 months after fibromyalgia diagnosis in active duty service members from 2015 to 2022.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and Methods<\/jats:title>\n                  <jats:p>Medical record information from active duty service members who received a fibromyalgia diagnosis between 2015 and 2022 in the U.S. Military Health System was included in the analyses. Bivariate analyses evaluated inequities in co-occurring diagnoses (abdominal and pelvic pain, insomnia, psychiatric conditions, and migraines), health care (acupuncture and dry needling, biofeedback and other muscle relaxation, chiropractic and osteopathic treatments, exercise classes and activities, massage therapy, behavioral health care, other physical interventions, physical therapy, self-care management, and transcutaneous electrical nerve stimulation), and prescription receipt (anxiolytics, gabapentinoids, muscle relaxants, non-opioid pain medication, opioids, selective serotonin and norepinephrine inhibitors, and tramadol) across race and ethnicity and assigned sex. Pairwise comparisons were made using a false discovery rate adjusted P value.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Overall, 13,663 service members received a fibromyalgia diagnosis during the study period. Approximately 52% received a follow-up visit within 3 months of index diagnosis. Most service members received a co-occurring psychiatric diagnosis (35%), followed by insomnia (24%), migraines (20%), and abdominal and pelvic pain diagnoses (19%) fibromyalgia diagnosis. At least half received exercise classes and activities (52%), behavioral health care (52%), or physical therapy (50%). Less commonly received therapies included other physical interventions (41%), chiropractic\/osteopathic care (40%), massage therapy (40%), transcutaneous electrical nerve stimulation (33%), self-care education (29%), biofeedback and other muscle relaxation therapies (22%), and acupuncture or dry needling (14%). The most common prescriptions received were non-opioid pain medications (72%), followed by muscle relaxers (44%), opioids (32%), anxiolytics (31%), gabapentinoids (26%), serotonin-norepinephrine reuptake inhibitor (21%), selective serotonin reuptake inhibitors (20%), and tramadol (15%). There were many inequities identified across outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Overall, service members diagnosed with fibromyalgia received variable guideline-congruent health care within the 3 months before and after fibromyalgia diagnosis. Almost 1 in 3 service members received an opioid prescription, which has been explicitly recommended against use in guidelines. Pairwise comparisons indicated unwarranted variation across assigned sex and race and ethnicity in both co-occurring health conditions and care receipt. Underlying reasons for health and health care inequities can be multisourced and modifiable. It is unclear whether the U.S. Military Health System has consolidated patient resources to support patients living with fibromyalgia and if so, the extent to which such resources are accessible and known to patients and their clinicians.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/milmed\/usae384","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T13:02:32Z","timestamp":1723554152000},"page":"e666-e674","source":"Crossref","is-referenced-by-count":2,"title":["Fibromyalgia Diagnosis and Treatment Receipt in the U.S. Military Health System"],"prefix":"10.1093","volume":"190","author":[{"given":"Germaine F","family":"Herrera","sequence":"first","affiliation":[{"name":"Defense and Veterans Center for Integrative Pain Management, Department of Anesthesiology, Uniformed Services University , Bethesda, MD 20814,","place":["USA"]},{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. , Bethesda, MD 20817,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia K","family":"Carre\u00f1o","sequence":"additional","affiliation":[{"name":"Department of Psychology, George Mason University , Fairfax, VA 22030,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ysehak","family":"Wondwossen","sequence":"additional","affiliation":[{"name":"Eisenhower Army Medical Center , Fort Eisenhower, GA 30905,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G","family":"Velosky","sequence":"additional","affiliation":[{"name":"Defense and Veterans Center for Integrative Pain Management, Department of Anesthesiology, Uniformed Services University , Bethesda, MD 20814,","place":["USA"]},{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. , Bethesda, MD 20817,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6201-3793","authenticated-orcid":false,"given":"Michael S","family":"Patzkowski","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Brooke Army Medical Center , Fort Sam Houston, TX 78234-6200,","place":["USA"]},{"name":"Department of Anesthesiology, Uniformed Services University , Bethesda, MD 20814,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3815-2571","authenticated-orcid":false,"given":"Krista B","family":"Highland","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Uniformed Services University , Bethesda, MD 20814,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,12]]},"reference":[{"issue":"8","key":"2025031111134843100_R1","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1097\/j.pain.0000000000001870","article-title":"\u201cNo one wants to look after the fibro patient.\u201d Understanding models, and patient perspectives, of care for fibromyalgia: reviews of current evidence","volume":"161","author":"Doebl","year":"2020","journal-title":"Pain"},{"issue":"11","key":"2025031111134843100_R2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41584-020-00506-w","article-title":"Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment","volume":"16","author":"Sarzi-Puttini","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"2025031111134843100_R3","doi-asserted-by":"publisher","DOI":"10.1057\/s41599-021-00918-3","article-title":"Epistemic injustice in the age of evidence-based practice: the case of fibromyalgia","volume":"8","author":"Heggen","year":"2021","journal-title":"Humanit Soc Sci Commun"},{"issue":"1","key":"2025031111134843100_R4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.semarthrit.2020.10.006","article-title":"The prevalence of psychiatric and chronic pain comorbidities in fibromyalgia: an ACTTION systematic review","volume":"51","author":"Kleykamp","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"2025031111134843100_R5","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.jad.2020.01.129","article-title":"Depression and trait-anxiety mediate the influence of clinical pain on health-related quality of life in fibromyalgia","volume":"265","author":"Galvez-S\u00e1nchez","year":"2020","journal-title":"J Affect Disord"},{"issue":"4","key":"2025031111134843100_R6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/1756-185X.14293","article-title":"Efficacy of adding pain neuroscience education to a multimodal treatment in fibromyalgia: a systematic review and meta-analysis","volume":"25","author":"Saracoglu","year":"2022","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"2025031111134843100_R7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-14213-x","article-title":"Effect of different types of exercise in adult subjects with fibromyalgia: a systematic review and meta-analysis of randomised clinical trials","volume":"12","author":"Couto","year":"2022","journal-title":"Sci Rep"},{"issue":"8","key":"2025031111134843100_R8","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1097\/j.pain.0000000000002500","article-title":"Efficacy of nonpharmacological interventions for individual features of fibromyalgia: a systematic review and meta-analysis of randomised controlled trials","volume":"163","author":"Kundakci","year":"2022","journal-title":"Pain"},{"issue":"5","key":"2025031111134843100_R9","doi-asserted-by":"publisher","first-page":"e2212939","DOI":"10.1001\/jamanetworkopen.2022.12939","article-title":"Comparison of amitriptyline and US food and drug administration\u2013approved treatments for fibromyalgia: a systematic review and network meta-analysis","volume":"5","author":"Farag","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2025031111134843100_R10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1001\/jamainternmed.2020.5651","article-title":"Association of therapies with reduced pain and improved quality of life in patients with fibromyalgia: a systematic review and meta-analysis","volume":"181","author":"Mascarenhas","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"7","key":"2025031111134843100_R11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254642","article-title":"Self-management for chronic widespread pain including fibromyalgia: a systematic review and meta-analysis","volume":"16","author":"Geraghty","year":"2021","journal-title":"PLoS One"},{"key":"2025031111134843100_R12","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.152101","article-title":"International, multidisciplinary Delphi consensus recommendations on non-pharmacological interventions for fibromyalgia","volume":"57","author":"Kundakci","year":"2022","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"2025031111134843100_R13","first-page":"293","article-title":"Analysis of real-world dosing patterns for the 3 FDA-approved medications in the treatment of fibromyalgia","volume":"11","author":"White","year":"2018","journal-title":"Am Health Drug Benefits"},{"issue":"9","key":"2025031111134843100_R14","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/AJP.0000000000000738","article-title":"Insomnia increases symptom severity and health care utilization in patients with fibromyalgia: a population-based study","volume":"35","author":"Huang","year":"2019","journal-title":"Clin J Pain"},{"issue":"11","key":"2025031111134843100_R15","first-page":"8","article-title":"Fibromyalgia: prevalence and burden of disease among active component service members, U.S. Armed Forces, 2018","volume":"27","author":"Husle","year":"2020","journal-title":"MSMR"},{"issue":"2","key":"2025031111134843100_R16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1089\/big.2014.0055","article-title":"The U.S. army person-event data environment: a military-civilian big data enterprise","volume":"3","author":"Vie","year":"2015","journal-title":"Big Data"},{"issue":"7","key":"2025031111134843100_R17","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1089\/acm.2017.0290","article-title":"Associations of early treatments for low-back pain with military readiness outcomes","volume":"24","author":"Larson","year":"2018","journal-title":"J Altern Complement Med"},{"key":"2025031111134843100_R18","article-title":"Package \u2018ggplot2\u02b9. Create elegant data visualisations using the grammar of graphics version 3.4.0","author":"Wickham","year":"2024"},{"issue":"43","key":"2025031111134843100_R19","doi-asserted-by":"publisher","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source Softw"},{"key":"2025031111134843100_R20","doi-asserted-by":"crossref","article-title":"rcompanion: functions to support extension education program evaluation","author":"Mangiafico","DOI":"10.32614\/CRAN.package.rcompanion"},{"key":"2025031111134843100_R21","article-title":"Fibromyalgia","author":"Chan"},{"issue":"2","key":"2025031111134843100_R22","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia","volume":"76","author":"Macfarlane","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2025031111134843100_R23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/RHU.0000000000001273","article-title":"Opioid use in fibromyalgia continues despite guidelines that do not support its efficacy or risk","volume":"27","author":"Bruce","year":"2021","journal-title":"J Clinic Rheumatol"},{"issue":"6","key":"2025031111134843100_R24","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1097\/j.pain.0000000000002528","article-title":"Mechanisms of injustice: what we (do not) know about racialized disparities in pain","volume":"163","author":"Mathur","year":"2022","journal-title":"Pain"},{"key":"2025031111134843100_R25","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2022.845513","article-title":"Exploring the experiences of co-morbid pain and depression in older African American women and their preferred management strategies","volume":"3","author":"Drazich","year":"2022","journal-title":"Front Pain Res"},{"issue":"16","key":"2025031111134843100_R26","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1073\/pnas.1516047113","article-title":"Racial bias in pain assessment and treatment recommendations, and false beliefs about biological differences between blacks and whites","volume":"113","author":"Hoffman","year":"2016","journal-title":"Proc Natl Acad Sci U.S.A"},{"issue":"1","key":"2025031111134843100_R27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pmn.2017.11.008","article-title":"Pain, racial discrimination, and depressive symptoms among African American Women","volume":"19","author":"Walker Taylor","year":"2018","journal-title":"Pain Manag Nurs"},{"issue":"1","key":"2025031111134843100_R28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11606-023-08473-0","article-title":"Pain care disparities and the use of virtual care among racial-ethnic minority groups during COVID-19","volume":"39","author":"Javier","year":"2024","journal-title":"J Gen Intern Med"},{"issue":"24","key":"2025031111134843100_R29","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20247185","article-title":"Assessing ethnic minority representation in fibromyalgia clinical trials: a systematic review of recruitment demographics","volume":"20","author":"Henley","year":"2023","journal-title":"Int J Environ Res Public Health"},{"issue":"20","key":"2025031111134843100_R30","doi-asserted-by":"publisher","first-page":"5770","DOI":"10.1080\/09638288.2021.1954706","article-title":"Cognitive behavioral therapy for insomnia (CBT-i) in patients with fibromyalgia: a systematic review and meta-analysis","volume":"44","author":"Climent-Sanz","year":"2022","journal-title":"Disabil Rehabil"},{"issue":"10","key":"2025031111134843100_R31","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100104","article-title":"Efficacy of cognitive-behavioral therapies in fibromyalgia syndrome \u2014 a systematic review and metaanalysis of randomized controlled trials","volume":"37","author":"Kathrin","year":"2010","journal-title":"J Rheumatol"},{"issue":"2","key":"2025031111134843100_R32","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/ejp.1121","article-title":"Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome \u2013 a systematic review and meta-analysis of randomized controlled trials","volume":"22","author":"Bernardy","year":"2018","journal-title":"Eur J Pain"},{"key":"2025031111134843100_R33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09638288.2024.2331069","article-title":"Effectiveness of transcutaneous electrical nerve stimulation improves pain intensity, disability and quality of life in patients with fibromyalgia syndrome: a systematic review with meta-analysis","author":"Garc\u00eda-L\u00f3pez","year":"2024","journal-title":"Disabil Rehabil"},{"issue":"8","key":"2025031111134843100_R34","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1097\/j.pain.0000000000002876","article-title":"The dose-dependent effects of transcutaneous electrical nerve stimulation for pain relief in individuals with fibromyalgia: a systematic review and meta-analysis","volume":"164","author":"Amer-Cuenca","year":"2023","journal-title":"Pain"},{"issue":"null","key":"2025031111134843100_R35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2147\/JPR.S351320","article-title":"Effect of acupuncture on pain, fatigue, sleep, physical function, stiffness, well-being, and safety in fibromyalgia: a systematic review and meta-analysis","volume":"15","author":"Zheng","year":"2022","journal-title":"J Pain Res"},{"key":"2025031111134843100_R36","doi-asserted-by":"crossref","DOI":"10.1089\/acm.2017.0236","article-title":"Complementary and alternative medicine services in the military health system","author":"Herman","year":"2017"},{"issue":"4","key":"2025031111134843100_R37","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.mayocpiqo.2019.07.003","article-title":"Use of complementary and integrative therapies by fibromyalgia patients: a 14-year follow-up study","volume":"3","author":"Mohabbat","year":"2019","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"2025031111134843100_R38","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.152060","article-title":"The economic burden of fibromyalgia: a systematic literature review","volume":"56","author":"D\u2019Onghia","year":"2022","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"2025031111134843100_R39","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-07849-y","article-title":"The importance of chronic conditions for potentially avoidable hospitalizations among non-Hispanic Black and non-Hispanic White older adults in the US: a cross-sectional observational study","volume":"22","author":"J\u00f8rgensen","year":"2022","journal-title":"BMC Health Serv Res"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/190\/3-4\/e666\/58808630\/usae384.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/190\/3-4\/e666\/58808630\/usae384.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T11:14:24Z","timestamp":1741691664000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/190\/3-4\/e666\/7732607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,12]]},"references-count":39,"journal-issue":{"issue":"3-4","published-online":{"date-parts":[[2024,8,12]]},"published-print":{"date-parts":[[2025,2,27]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usae384","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"value":"0026-4075","type":"print"},{"value":"1930-613X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,8,12]]}}}